All Stories

  1. Controlled Photoiniferter RAFT-Based Development of Linear Polymers Induced by the Presence of a Peptide to Produce Synthetic Antibody Substitutes Applicable to Immunofluorescence Imaging Techniques
  2. A universal cannabinoid CB1 and CB2 receptor TR-FRET kinetic ligand-binding assay
  3. Effects of intramuscular administration of Platelet-Rich Plasma on denervated muscle after peripheral nerve injury
  4. Impact of Omega-3 on Endocannabinoid System Expression and Function, Enhancing Cognition and Behavior in Male Mice
  5. Tuning the properties of peptide imprinted nanoparticles for protein immunoprecipitation using magnetic streptavidin beads
  6. PLCβ1 by-passes early growth response -1 to induce the differentiation of neuronal cells
  7. PLCβ1 By-Passes Early Growth Response -1 to Induce and Maintain the Differentiation of Neuronal Cells
  8. Endocannabinoid 2-Arachidonoylglycerol Synthesis and Metabolism at Neuronal Nuclear Matrix Fractions Derived from Adult Rat Brain Cortex
  9. Up-regulation of CB1 cannabinoid receptors located at glutamatergic terminals in the medial prefrontal cortex of the obese Zucker rat
  10. Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB1 receptor density in cell membranes: an alternative to radioligand binding methods
  11. Isolation of Platelet-Derived Exosomes from Human Platelet-Rich Plasma: Biochemical and Morphological Characterization
  12. A linear-polymer-based lactoferrin-selective recognition element for an ELISA mimic: A proof of concept
  13. Subsynaptic Distribution, Lipid Raft Targeting and G Protein-Dependent Signalling of the Type 1 Cannabinoid Receptor in Synaptosomes from the Mouse Hippocampus and Frontal Cortex
  14. Solid-phase synthesis of imprinted nanoparticles as artificial antibodies against the C-terminus of the cannabinoid CB1 receptor: exploring a viable alternative for bioanalysis
  15. Fit-for-purpose based testing and validation of antibodies to amino- and carboxy-terminal domains of cannabinoid receptor 1
  16. Lack of the Transient Receptor Potential Vanilloid 1 Shifts Cannabinoid-Dependent Excitatory Synaptic Plasticity in the Dentate Gyrus of the Mouse Brain Hippocampus
  17. The Absence of the Transient Receptor Potential Vanilloid 1 Directly Impacts on the Expression and Localization of the Endocannabinoid System in the Mouse Hippocampus
  18. Effects of Platelet-Rich Plasma on Cellular Populations of the Central Nervous System: The Influence of Donor Age
  19. Biological and structural effects after intraosseous infiltrations of age‐dependent platelet‐rich plasma: An in vivo study
  20. Intermittent ethanol exposure during adolescence impairs cannabinoid type 1 receptor-dependent long-term depression and recognition memory in adult mice
  21. Ketaminaren eragin antidepresiboak. Ekintza mekanismo berriak farmako antidepresiboen bilaketarako
  22. Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders
  23. Data for the morphometric characterization of NT2-derived postmitotic neurons
  24. Highly efficient generation of glutamatergic/cholinergic NT2-derived postmitotic human neurons by short-term treatment with the nucleoside analogue cytosine β-d-arabinofuranoside
  25. New Insights into Gene Delivery to Human Neuronal Precursor NT2 Cells: A Comparative Study between Lipoplexes, Nioplexes, and Polyplexes
  26. Issue Cover (March 2015)
  27. Nuclear diacylglycerol lipase-α in rat brain cortical neurons: evidence of 2-arachidonoylglycerol production in concert with phospholipase C-β activity
  28. Nuclear phospholipase C-β1 and diacylglycerol LIPASE-α in brain cortical neurons
  29. Chronic effects of corticosterone on GIRK1-3 subunits and 5-HT1A receptor expression in rat brain and their reversal by concurrent fluoxetine treatment
  30. Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of AD
  31. Validation of an LC–ESI-MS/MS method for the quantitation of phosphodiesterase-5 inhibitors and their main metabolites in rat serum and brain tissue samples
  32. Cellular neurochemical characterization and subcellular localization of phospholipase C β1 in rat brain
  33. EBI2 regulates CXCL13‐mediated responses by heterodimerization with CXCR5
  34. Levels of Gsα(short and long), Gαolf and Gβ(common) subunits, and calcium-sensitive adenylyl cyclase isoforms (1, 5/6, 8) in post-mortem human brain caudate and cortical membranes: Comparison with rat brain membranes and potential stoichiometric relati...
  35. Giprotein coupling to adenosine A1–A2Areceptor heteromers in human brain caudate nucleus
  36. Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas
  37. Allosteric modulation of 5-HT1A receptors by zinc: Binding studies
  38. Distribution and neurochemical characterization of neurons expressing GIRK channels in the rat brain
  39. Immunohistochemical localization of CB1 cannabinoid receptors in frontal cortex and related limbic areas in obese Zucker rats: Effects of chronic fluoxetine treatment
  40. Brain endocannabinoid system is involved in fluoxetine-induced anorexia
  41. Simultaneous determination of citalopram, fluoxetine and their main metabolites in human urine samples by solid-phase microextraction coupled with high-performance liquid chromatography
  42. Determination of fluoxetine, norfluoxetine and their enantiomers in rat plasma and brain samples by liquid chromatography with fluorescence detection
  43. Levels of G-protein αq/11 subunits and of phospholipase C-β(1–4), -γ, and -δ1 isoforms in postmortem human brain caudate and cortical membranes: Potential functional implications
  44. Brain G protein-dependent signaling pathways in Down syndrome and Alzheimer’s disease
  45. Transmembrane signaling through phospholipase C-β in the developing human prefrontal cortex
  46. Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates
  47. Differential Postmortem Delay Effect on Agonist-Mediated Phospholipase Cβ Activity in Human Cortical Crude and Synaptosomal Brain Membranes
  48. Lista de comprobación (checklist) abreviada para la evaluación de artículos de investigación biomédica básica
  49. Determination of methylarginines in human plasma by HPLC with pre-column derivatization using naphthalenedicarboxaldehyde as fluorogenic agent
  50. Design, Synthesis and Pharmacological Evaluation of 5-Hydroxytryptamine1a Receptor Ligands to Explore the Three-Dimensional Structure of the Receptor
  51. Reduced phospholipase C-β activity and isoform expression in the cerebellum of TS65DN mouse: A model of down syndrome
  52. Determination of catecholamines and their metabolites in human plasma using liquid chromatography with coulometric multi-electrode cell-design detection
  53. Regulation of phospholipase Cβ activity by muscarinic acetylcholine and 5-HT2 receptors in crude and synaptosomal membranes from human cerebral cortex
  54. Transmembrane signaling through phospholipase C in cortical and hippocampal membranes of psychogenetically selected rat lines
  55. Modelling the changes induced by chronic desipramine treatment on the factors governing the agonism at prejunctional α2-adrenoceptors
  56. Action on noradrenergic transmission of an anticholinesterase: 9-amino-1,2,3,4-tetrahydroacridine
  57. Analysis of agonism at functional prejunctional of rat vas deferens using operational and null approaches
  58. Selective enrichment with α1A- and α1B-adrenoceptor subtypes in rat brain cortical membranes
  59. In vivo recovery of α1-adrenoceptors in rat myocardial tissue after alkylation with phenoxybenzamine
  60. Modulation of the phospholipase C activity in rat brain cortical membranes by simultaneous activation of distinct monoaminergic and cholinergic muscarinic receptors
  61. Modulation of α1-adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake
  62. Mechanisms underlying the differential sensitivity to a1-adrenoceptor activation in the bisected rat vas deferens
  63. Effects of chronic antidepressant treatment on ?1- and ?2-adrenoceptors in the rat anococcygeus muscle
  64. Adaptational changes of α1-adrenoceptors in the bisected rat vas deferens after chronic inhibition of neuronal noradrenaline uptake
  65. Paraxanthine displaces the binding of [3H]SCH 23390 from rat striatal membranes
  66. Differential effects of chronic treatment with mianserin and protryptiline on rat brain corticalα1-adrenoceptors
  67. Effects of St−587 on the α-adrenoceptors in the Bisected Rat Vas Deferens
  68. BHT-920 and LY-171555 (quinpirole) have similar affinities for striatal D-2 dopamine receptors, and similar affinities for striatal D-1 dopamine receptors
  69. Structure-activity relationships among di- and tetramine disulfides related to benextramine